Centrifugation Conditions in the L-PRP Preparation Affect Soluble Factors Release and Mesenchymal Stem Cell Proliferation in Fibrin Nanofibers

被引:13
作者
Gomes de Melo, Bruna Alice [1 ]
Malheiros Luzo, Angela Cristina [2 ]
Santos Duarte Lana, Jose Fabio [3 ]
Andrade Santana, Maria Helena [1 ]
机构
[1] Univ Estadual Campinas, Sch Chem Engn, Dept Engn Mat & Bioproc, BR-13083852 Campinas, SP, Brazil
[2] Univ Estadual Campinas, Umbil Cord Blood Bank, Hematol & Hemotherapy Ctr, BR-13083878 Campinas, SP, Brazil
[3] Bone & Cartilage Inst, BR-13334170 Indaiatuba, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
platelet; leukocyte; L-PRP; centrifugation; fibrin; nanofiber; growth factor; cytokine; mesenchymal stem cells; PLATELET-RICH PLASMA; GROWTH-FACTOR; ADIPOSE-TISSUE; IL-8; GENE; IN-VITRO; TGF-BETA; BLOOD; CLASSIFICATION; INTERLEUKIN-8; INFLAMMATION;
D O I
10.3390/molecules24152729
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leukocyte and platelet-rich plasma (L-PRP) is an autologous product that when activated forms fibrin nanofibers, which are useful in regenerative medicine. As an important part of the preparation of L-PRP, the centrifugation parameters may affect the release of soluble factors that modulate the behavior of the cells in the nanofibers. In this study, we evaluated the influences of four different centrifugation conditions on the concentration of platelets and leukocytes in L-PRP and on the anabolic/catabolic balance of the nanofiber microenvironment. Human adipose-derived mesenchymal stem cells (h-AdMSCs) were seeded in the nanofibers, and their viability and growth were evaluated. L-PRPs prepared at 100x g and 100 + 400x g released higher levels of transforming growth factor (TGF)-beta 1 and platelet-derived growth factor (PDGF)-BB due to the increased platelet concentration, while inflammatory cytokines interleukin (IL)-8 and tumor necrosis factor (TNF)-alpha were more significantly released from L-PRPs prepared via two centrifugation steps (100 + 400x g and 800 + 400x g) due to the increased concentration of leukocytes. Our results showed that with the exception of nanofibers formed from L-PRP prepared at 800 + 400x g, all other microenvironments were favorable for h-AdMSC proliferation. Here, we present a reproducible protocol for the standardization of L-PRP and fibrin nanofibers useful in clinical practices with known platelet/leukocyte ratios and in vitro evaluations that may predict in vivo results.
引用
收藏
页数:14
相关论文
共 58 条
[1]   Platelet-rich plasma for managing pain and inflammation in osteoarthritis [J].
Andia, Isabel ;
Maffulli, Nicola .
NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (12) :721-730
[2]   Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients [J].
Anitua, E. ;
Sanchez, M. ;
Nurden, A. T. ;
Zalduendo, M. M. ;
De la Fuente, M. ;
Azofra, J. ;
Andia, I. .
RHEUMATOLOGY, 2007, 46 (12) :1769-1772
[3]   Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture [J].
Anitua, E ;
Andía, I ;
Sanchez, M ;
Azofra, J ;
Zalduendo, MD ;
de la Fuente, M ;
Nurden, P ;
Nurden, AT .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2005, 23 (02) :281-286
[4]   Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid [J].
Anitua, E. ;
Sanchez, M. ;
De la Fuente, M. ;
Zalduendo, M. M. ;
Orive, G. .
KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2012, 20 (09) :1657-1665
[5]   Leukocyte Inclusion within a Platelet Rich Plasma-Derived Fibrin Scaffold Stimulates a More Pro-Inflammatory Environment and Alters Fibrin Properties [J].
Anitua, Eduardo ;
Zalduendo, Mar ;
Troya, Maria ;
Padilla, Sabino ;
Orive, Gorka .
PLOS ONE, 2015, 10 (03)
[6]  
[Anonymous], 2019, POLYMERS-BASEL
[7]  
[Anonymous], J STEM CELLS REGEN M
[8]  
[Anonymous], 2016, BMJ OPEN SPORT EXERC, DOI [10.1136/bmjsem-2015-000060, DOI 10.1136/BMJSEM-2015-000060]
[9]  
[Anonymous], ISRN HEMATOL, DOI [10. 1155/2014/176060, DOI 10.1155/2014/176060]
[10]  
[Anonymous], PRACT PAIN MANAG